ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 286

Clinical Significance and Prognostic Value of Neutrophil to Lymphocyte Ratio in Patients with Dermatomyositis

Jaehyung Hur1, Dong Jin Go2, Sang Wan Chung3, You Jung Ha3, Eun Ha Kang1, Jin Kyun Park4, Eun Young Lee2, Eun Bong Lee2, Yeong Wook Song4 and Yun Jong Lee5, 1Division of Rheumatology, Department of Internal Medicine, Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea, The Republic of, 2Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, The Republic of, 3Division of Rheumatology, Department of Internal Medicine, Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea, 4Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea, 5Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: dermatomyositis, lymphocytes, neutrophils and prognostic factors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Muscle Biology, Myositis and Myopathies - Poster I: Basic/Translational

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:  Recent studies have suggested that neutrophil to lymphocyte ratio (NLR) could be an emerging predictive marker of disease activity or mortality in patients with chronic inflammatory diseases, cardiovascular diseases or malignancies. This study was aimed to evaluate the clinical significance and prognostic value of NLR in patients with dermatomyositis.

Methods:  We retrospectively reviewed 176 patients with newly diagnosed dermatomyositis who satisfied Peter and Bohan criteria between August 2003 and January 2016. Clinical characteristics and laboratory findings were compared between survivor group and non-survivor group. Using the receiver operating characteristics curves, the cut-off value of NLR for predicting survival was calculated. Univariate and multivariate analyses using Cox proportional hazard model were performed to identify associated factors with survival.

Results:  During follow-up (range 0.22-119.4 months), 24 patients (13.6%) died. Non-survivor group had older age (p = 0.011), more interstitial lung disease (ILD, p = 0.015), higher NLR (p = 0.011), lower albumin (p < 0.001), and higher creatinine level (p = 0.005) than survivor group. NLR showed significant positive correlation with C-reactive protein (CRP, r = 0.386, p <0.001), creatine kinase (CK, r = 0.161, p = 0.036), and lactate dehydrogenase (LDH, r = 0.3253, p = 0.001), and negative correlation with albumin (r = -0.298, p <0.001). The optimal cut-off value of NLR for overall survival was 3.8 with the area under the curve of 0.717. According to the cut-off value of 3.8, we classified 87 patients (49.4 %) into the low NLR group and 83 patients (47.2 %) into the high NLR group. The higher NLR group was associated with fever (p = 0.001), the higher muscle enzymes (CK, p = 0.025; LDH, p = 0.001), higher CRP (p < 0.001), lower albumin (p < 0.001), high-dose glucocorticoid therapy (p = 0.031), acute interstitial pneumonia (p = 0.024) and death (p < 0.001). Kaplan-Meier analysis and log-rank test demonstrated a significant difference in survival curves according to NLR of 3.8 (p < 0.001). Cox hazard regression analysis showed that NLR >=3.8, low albumin, the presence of ILD and old age were independent predictors for death (Table 1).

Conclusion:  Our results demonstrated that higher level of the NLR was associated with worse overall survival and the NLR may play a role as an independent prognostic marker in patients with dermatomyositis.

  • Table 1. Multivariate Cox hazard regression analysis of risk factors for death in patients with dermatomyositis
    Variable

    Death

    HR

    95% CI

    p-value

    Age

    1.087

    1.038-1.137

    <0.001

    NLR >= 3.8

    4.905

    1.413-17.025

    0.012

    Interstitial lung disease

    3.421

    1.313-8.917

    0.012

    Albumin

    0.498

    0.270-0.921

    0.026


  • Disclosure: J. Hur, None; D. J. Go, None; S. W. Chung, None; Y. J. Ha, None; E. H. Kang, None; J. K. Park, None; E. Y. Lee, None; E. B. Lee, None; Y. W. Song, None; Y. J. Lee, None.

    To cite this abstract in AMA style:

    Hur J, Go DJ, Chung SW, Ha YJ, Kang EH, Park JK, Lee EY, Lee EB, Song YW, Lee YJ. Clinical Significance and Prognostic Value of Neutrophil to Lymphocyte Ratio in Patients with Dermatomyositis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/clinical-significance-and-prognostic-value-of-neutrophil-to-lymphocyte-ratio-in-patients-with-dermatomyositis/. Accessed .
    • Tweet
    • Click to email a link to a friend (Opens in new window) Email
    • Click to print (Opens in new window) Print

    « Back to 2016 ACR/ARHP Annual Meeting

    ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-significance-and-prognostic-value-of-neutrophil-to-lymphocyte-ratio-in-patients-with-dermatomyositis/

    Advanced Search

    Your Favorites

    You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

    All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

    Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

    Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

    Wiley

    • Online Journal
    • Privacy Policy
    • Permissions Policies
    • Cookie Preferences

    © Copyright 2025 American College of Rheumatology